Approval of funding of sildenafil for Raynaud's phenomenon and bosentan for children with pulmonary arterial hypertension 28 January 2013 Medicines Decision Approval of funding of sildenafil for Raynaud's phenomenon and bosentan for children with pulmonary arterial hypertension(external link)
